Health
Recurring glioblastomas with very few mutations are far more vulnerable to immunotherapies – News-Medical.Net
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling…
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Duke’s Preston Robert Tisch Brain Tumor Center provide potential answers. The team found that recurring glioblastoma…
-
Noosa News24 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General17 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News24 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026
-
Business21 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?